Hay algunas evidencias de que el uso a largo plazo de aspirina (en dosis bajas), de antiinflamatorios no esteroideos no selectivos y la erradicación del Helicobacter pylori pueden disminuir el riesgo de todos los cánceres gastrointestinales.[22]Brusselaers N, Lagergren J. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden. BMJ Open. 2018 Jul 7;8(7):e021869.
https://bmjopen.bmj.com/content/8/7/e021869.long
http://www.ncbi.nlm.nih.gov/pubmed/29982219?tool=bestpractice.com
[23]Ford AC, Yuan Y, Forman D, et al. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev. 2020 Jul 6;(7):CD005583.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005583.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/32628791?tool=bestpractice.com
[24]Bosetti C, Santucci C, Gallus S, et al. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019. Ann Oncol. 2020 May;31(5):558-68.
https://www.annalsofoncology.org/article/S0923-7534(20)36073-7/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32272209?tool=bestpractice.com
[ ]
Can Helicobacter pylori eradication prevent gastric neoplasia?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.3347/fullMostrarme la respuesta
]